Max Rossetto

Max Rossetto is an experienced professional in business development within the biotechnology and pharmaceutical sectors, currently serving as the Global Business Development Director for Microbial Therapeutics at SACCO SYSTEM since January 2023. With an extensive background, Max has held various director and managerial positions, including roles at ACN 643628228 Pty Ltd, CellProtect Australia Pty Ltd, and AcuraBio. Max has successfully contributed to companies such as AMRI and Carbogen AMCIS, focusing on integrated drug discovery and development, contract services, and market expansion across the Asia Pacific and Europe. Educational credentials include an MBA in International Business, a Master's in Biotechnology, and completion of the Company Director's Course from the Australian Institute of Company Directors.